SMITH KLINE & FRENCH LABORATORIES LIMITED

Accounts Submitted

Confirmation Statement Submitted 2 Oct 2024

Net assets £479.39M £9.15M 2023 year on year

Total assets £483.17M £11.98M 2023 year on year

Total Liabilities £3.78M £2.83M 2023 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

C/O Bdo Llp, 5 Temple Square Temple Street Liverpool L2 5RH

Credit Report

Discover SMITH KLINE & FRENCH LABORATORIES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2021–2023)

Cash in Bank

N/A

Net Assets

£479.39M

Increased by £9.15M (+2%)

Total Liabilities

£3.78M

Increased by £2.83M (+299%)

Turnover

N/A

Employees

N/A

Debt Ratio

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

4 active 24 resigned

Show resigned officers

						Status
Ciara Martha Lynch	Director	Irish	England	57	2 Mar 2020	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-director	United Kingdom	Unknown	—	2 Mar 2001	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-secretary	United Kingdom	Unknown	—	18 Jan 2002	Active
Glaxo Group Limited	Corporate-director	United Kingdom	Unknown	—	2 Mar 2001	Active

Shareholders

Shareholders (1)


Smithkline Beecham Limited	100.0%	1	Ordinary	13 Sept 2022

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Smithkline Beecham Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

SMITHKLINE BEECHAM LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

SMITH KLINE & FRENCH LABORATORIES LIMITED Current Company

BEECHAM GROUP PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

MAUNSELL INTERNATIONAL PROJECTS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
21 Oct 2025	Insolvency	Liquidation Voluntary Members Return Of Final Meeting	View(18 pages)
31 Oct 2024	Insolvency	Liquidation Voluntary Appointment Of Liquidator	View(3 pages)
31 Oct 2024	Insolvency	Liquidation Voluntary Declaration Of Solvency	View(5 pages)
31 Oct 2024	Resolution	Resolutions	View(1 page)
31 Oct 2024	Address	Change Registered Office Address Company With Date Old Address New Address	View(3 pages)